We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Hemagglutination Assay Kit Diagnoses and Monitors Treatment of Syphilis

By LabMedica International staff writers
Posted on 12 Jul 2011
A fast, reliable hemagglutination assay aids in detecting, diagnosing, and monitoring the treatment of syphilis.

The Treponema pallidum hemagglutination assay (TPHA) test is a qualitative and semiquantitative hemagglutination test for the presence of immunoglobulin G (IgG) and IgM antibodies to Treponema pallidum, the causative agent of syphilis in human serum and ethylenediaminetetraacetic acid (EDTA) plasma. More...
Serum is the sample of choice and any repeat or confirmatory testing must be done with serum.

The syphilis testing kit, a product of Arlington Scientific, Inc. (ASI; Springville, Utah, USA) contains 100 tests per vial and includes liquid controls. It does not need reconstitution and has up to 18-month shelf life (from date of manufacture). Two levels of controls are included: reactive, and nonreactive.

Blood tests for syphilis are divided into nontreponemal and treponemal tests. Nontreponemal tests are used initially and include venereal disease research laboratory (VDRL) and rapid plasma reagin (RPR). Positive results are often confirmed with a treponemal test such as TPHA or fluorescent treponemal antibody absorption test (FTA-Abs). ASI manufactures RPR, TPHA, and VDRL test kits and the ASiManager-AT, a digital agglutination card reader.

Related Links:

Arlington Scientific Inc.




Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
New
Automated Clinical Chemistry Analyzer
Envoy 500+
New
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Researchers identified blood-based genomic signatures characteristic of inflammatory breast cancer (photo courtesy of Shutterstock)

Liquid Biopsy Biomarkers Distinguish Inflammatory Breast Cancer and Support Monitoring

Inflammatory breast cancer is among the most aggressive forms of breast malignancy and remains challenging to diagnose and monitor. Obtaining tumor tissue can be difficult, and standard genome and RNA... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.